[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gu et al., 1995 - Google Patents

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

Gu et al., 1995

View PDF
Document ID
13503681689094043843
Author
Gu D
Wogensen L
Calcutt N
Xia C
Zhu S
Merlie J
Fox H
Lindstrom J
Powell H
Sarvetnick N
Publication year
Publication venue
The Journal of experimental medicine

External Links

Snippet

Abnormal humoral responses toward motor end plate constituents in muscle induce myasthenia gravis (MG). To study the etiology of this disease, and whether it could be induced by host defense molecules, we examined the consequences of interferon (IFN) …
Continue reading at europepmc.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Gu et al. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.
Cohen et al. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+ CD25+ cells
Goverman et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
Mueller et al. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.
Lorentzen et al. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant
JP3165148B2 (en) Diagnosis and treatment of insulin-dependent diabetes
A Kleopa Autoimmune channelopathies of the nervous system
HU220357B (en) Method and compositions for treatment of autoimmune diseases by use of bystander antigen
Mauri et al. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.
Vogel et al. Deletional tolerance prevents AQP4‐directed autoimmunity in mice
Chen et al. Antrum mucosal protein-18 peptide targets tight junctions to protect and heal barrier structure and function in models of inflammatory bowel disease
Brostoff Immunological responses to myelin and myelin components
Saï et al. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524–543 reduces cyclophosphamide-accelerated diabetes
McPherson et al. Resting CD8 T cells recognize β‐galactosidase expressed in the immune‐privileged retina and mediate autoimmune disease when activated
Hikita et al. Osteopontin is proinflammatory in experimental autoimmune uveitis
JP3558347B2 (en) Alpha B crystallin for use in the diagnosis and treatment of autoimmune diseases, especially multiple sclerosis
Kirschstein et al. Stereotactically injected kv1. 2 and CASPR2 antisera cause differential effects on CA1 synaptic and cellular excitability, but both enhance the vulnerability to pro-epileptic conditions
KR19990007893A (en) Central nervous system (CNS) axon growth modulator, compositions, cells and methods for implementing and using the same
Xia et al. Myasthenia Gravis-like Syndrome Induced by Expression of Interferon 3/in the Neuromuscular Junction By Danling Gu,* Lise Wogensen,* Nigel A. Calcutt,~
Brunn et al. CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine p0106–125-induced experimental autoimmune neuritis
JPH05502854A (en) Tolerogenic immunoglobulin-protein conjugate
Lipscomb et al. The effect of neonatal thymectomy on the induction of autoimmune orchitis in rats
EP0544862B1 (en) Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal diseases and related conditions
JP2023527205A (en) Improved vaccine formulation
Sabnis et al. Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain